Paige AI

Paige AI

Paid ✓ Verified
BusinessResearchOther digital pathologycancer diagnosticshealthcare AI

Paige AI is an FDA-cleared computational pathology platform that uses deep learning to help pathologists diagnose cancer faster and with greater accuracy.

Follow:
paige.ai
Paige AI
4.7/5 (20 ratings)
Share:

📋 About Paige AI

Paige AI is a clinical-grade computational pathology platform that applies deep learning to digitized tissue slides to help pathologists detect and diagnose cancer. The company was founded by researchers and clinicians from Memorial Sloan Kettering and has received FDA clearance for its flagship prostate cancer detection product. Paige AI does not replace pathologists but acts as a second reader that flags regions of interest, quantifies suspicious patterns, and surfaces cases that need priority attention.

Key Features of Paige AI

1

FDA-Cleared Prostate Detection

Paige Prostate Detect is the first AI product for pathology to receive FDA clearance as a diagnostic aid. This is a major regulatory milestone that distinguishes Paige AI from research-only tools. Clearance enables routine clinical use in supported workflows.

2

Whole-Slide Image Analysis

The platform analyzes gigapixel whole-slide images at multiple magnifications, mirroring the way pathologists actually examine tissue. Region-of-interest heatmaps guide attention to areas most likely to contain cancer. This is dramatically faster than manual scanning.

3

Multi-Cancer Coverage

Beyond prostate, Paige AI offers models for breast, colon, lymph node, and other cancer types, with ongoing expansion into additional tumor sites. This breadth lets labs adopt a single platform across most of their casework rather than juggling point solutions.

4

Biomarker Quantification

Paige AI quantifies biomarkers relevant to treatment decisions such as hormone receptor status and immune infiltration. This is particularly valuable in oncology where treatment depends on precise biomarker thresholds. Quantification is consistent across pathologists and laboratories.

5

LIS and Viewer Integrations

The platform integrates with major laboratory information systems and digital pathology viewers so pathologists work in the tools they already use. This removes workflow friction that often blocks adoption of new diagnostic tools. Reports flow back into LIS for reporting.

6

Research and Clinical Trial Support

Pharmaceutical companies use Paige AI for consistent biomarker scoring across clinical trial cohorts, supporting regulatory submissions. The platform's auditability is essential for regulated research. Study-specific models can be trained on sponsor data under appropriate governance.

🎯 Use Cases for Paige AI

Hospital pathology departments use Paige AI as a second reader for prostate biopsies, catching subtle foci of cancer that might otherwise be missed and prioritizing cases that need urgent sign-out. Reference laboratories process large daily volumes of biopsies more efficiently by using AI to triage cases, reduce pathologist eye-strain, and standardize quality across a distributed team. Academic medical centers use Paige AI for research into rare subtypes, tumor heterogeneity, and outcome prediction, combining the platform's quantification with their own clinical data. Pharmaceutical companies running oncology trials use Paige AI for consistent biomarker scoring across sites, improving regulatory submission quality and trial reliability. Labs in rural or underserved regions use the platform to provide a consistent level of AI-assisted second opinion even where subspecialty pathology expertise is hard to staff.

⚖️ Paige AI Pros & Cons

Advantages

  • FDA-cleared products suitable for routine clinical use
  • Trained on one of the largest curated pathology archives
  • Integrates with existing LIS and pathology viewers
  • Multi-cancer coverage across a single platform
  • Supports both clinical diagnosis and clinical trial workflows

Drawbacks

  • Requires digitized whole-slide imaging infrastructure to deploy
  • Designed for clinical and research institutions rather than individuals
  • Regulatory clearance varies by country and product

📖 How to Use Paige AI

1

Contact Paige AI via paige.ai to arrange a clinical or research engagement.

2

Ensure your laboratory has digitized whole-slide imaging infrastructure in place.

3

Work with Paige AI to integrate with your LIS and digital pathology viewer.

4

Complete validation on local data as required by your regulatory region.

5

Enable AI-assisted reading for supported cancer types in the pathologist workflow.

6

Review analytics on turnaround time, detection rate, and workflow impact to expand deployment.

Paige AI FAQ

Yes. Paige Prostate Detect received FDA clearance as a diagnostic aid. Other products have various regulatory statuses depending on region.

No. Paige AI acts as an assistive second reader. Pathologists remain responsible for diagnosis and sign-out.

Prostate, breast, colon, lymph node, and additional tumor types with continuing expansion.

Yes. Paige AI supports biomarker scoring and analysis workflows in clinical trials under appropriate governance.

Yes. Paige AI requires whole-slide digital pathology imaging. Labs using glass-only workflows would need to digitize first.

Related to Paige AI

Featured on WhatIf.ai

Add this badge to your website to show you're listed on WhatIf AI

Alternatives to Paige AI